Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by NH TherAguix SA

NH TherAguix Announces Continuation of the Phase II NANOBRAINMETS Trial in the Treatment of Brain Metastases after Completion of a Futility Analysis
From NH TherAguix SA
Via Business Wire
NH TherAguix Announces Publication of Groundbreaking Study on AGuIX® Nanoparticles Enhancing Cervical Cancer Treatment
From NH TherAguix SA
Via GlobeNewswire
NH TherAguix Announces the completion of Phase I Recruitment for the Pancreas Cohort and the entry into Phase II in the NANOSMART phase Ib/II trial.
From NH TherAguix SA
Via GlobeNewswire
Publication of an article in Nature's Scientific Reports describing the quantification of novel radio-enhancer AGuIX® developed in brain metastases
From NH TherAguix SA
Via GlobeNewswire
NH TherAguix receives FDA Fast Track designation
From NH TherAguix SA
Via GlobeNewswire
NH TherAguix appoints Jean-Philippe DEL as Chief Financial Officier
From NH TherAguix SA
Via GlobeNewswire
Successful completion of recruitment in NANORAD 2, a Phase 2 Clinical Trial of AGuIX® with whole brain radiation therapy in brain metastasis
From NH TherAguix SA
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.